Universal-Beteiligungs- und Servicegesellschaft
RCUS icon

Universal-Beteiligungs- und Servicegesellschaft’s Arcus Biosciences RCUS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$684K Sell
31,663
-2,956
-9% -$63.8K ﹤0.01% 1631
2025
Q4 		$825K Buy
+34,619
New +$706K ﹤0.01% 1553
2025
Q2 		– Sell
-17,631
Closed -$138K – 2094
2025
Q1 		$138K Buy
+17,631
New +$204K ﹤0.01% 1928

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RCUS Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Arcus Biosciences (RCUS) stake by 8.5% in Q1 2026, selling an estimated $63.8K and leaving 31,663 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RCUS in Q1 2025 and has held it in 3 quarters since. The position peaked at $825K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 31,663 shares of Arcus Biosciences worth $684K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 2,956 Arcus Biosciences shares in Q1 2026, an estimated $63.8K.
  • Arcus Biosciences made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1631 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Arcus Biosciences in Q1 2025 and has held it in 3 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Arcus Biosciences position peaked at $825K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.